MYNZ
Mainz Biomed N.V. Ordinary Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
MYNZ Stock Analysis: Buy, Sell, or Hold?
$0.84
+0.02 (+2.07%)
â˛
5d:
-7.24%
30d:
-2.44%
90d:
-21.84%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (82%)
Quality Score
42/100
Position
FAIR
Forward P/E & Valuation
-0.6x
Next 12M consensus est.
Wall Street Target
$14.00
+1558.6% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$0.59 / $0.94
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: MYNZ is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When MYNZ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: MYNZ is currently trading at $0.84, which is considered fair based on recent price action.
Technical Outlook: Technically, MYNZ is in a strong downtrend. Immediate support is located at $0.59, while resistance sits at $0.94.
Market Sentiment: MYNZ scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.00 (+1558.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MYNZ is in a strong downtrend. Immediate support is located at $0.59, while resistance sits at $0.94.
Market Sentiment: MYNZ scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.00 (+1558.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
42/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
81.6%
Trading Range & Key Levels
Support Level
$0.59
Resistance Level
$0.94
Current Trend
Strong Downtrend
Technical data as of
Mar 11, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Trading 1558.6% below Wall St target ($14.00)
- WARNING: Composite score 42/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.63
Wall Street Target
$14.00
(+1558.6%)
Revenue Growth (YoY)
-44.9%
Share MYNZ Analysis
Share this live MYNZ analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (MYNZ)
Bullish
3 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Mar 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Mainz Biomed announces the appointment of Robert Liscouski as Chairman of the Board and plans to change its name to Quantum Cyber and Nasdaq ticker symbol to QUCY.
Key Retail Themes:
company name change and leadership appointment
cyber security expansion plans
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:02 PM ET
Data refreshes hourly during market hours. Next update: 8:02 PM
Data refreshes hourly during market hours. Next update: 8:02 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MYNZ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$201 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$416 | 67 BUY |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
27 analysts |
$752 | 48 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$260 | 50 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive MYNZ Research Pages
